WCLC 2025 - Posters & ePosters-P1.11.52 Impact of Disease Progression on Pros in Patients Receiving Cemiplimab/Chemotherapy Versus Chemotherapy for aNSCLC: EMPOWER-Lung 3 Part 2

P1.11.52 Impact of Disease Progression on Pros in Patients Receiving Cemiplimab/Chemotherapy Versus Chemotherapy for aNSCLC: EMPOWER-Lung 3 Part 2

Asset Subtitle

Konstantin Penkov

Meta Tag

Speaker Konstantin Penkov

Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy